News
FDA unveils fast-track review path for 'national priorities'
FDA Commissioner Marty Makary has revealed a new priority review …
21053 items found
Market Access
Makary: Drugs don’t have to take 10 years to get to market
FDA Commissioner Dr Martin Makary took the stage at BIO 2025 to …
News
23andMe fined £2.31m over UK users' genetic data breach
Right after the announcement of a $305 million buyout by its former …
R&D
Healey shades Trump as she announces $40M in tax incentives
Massachusetts Governor Maura Healey took some oblique shots at the …
News
FDA green lights CSL's once-monthly HAE drug Andembry
CSL has FDA approval for its new drug to prevent hereditary …
News
Caris swells its planned IPO, seeking $5.7bn valuation
Caris Life Sciences, which specialises in the use of artificial …
News
Update: Rumour confirmed as Lilly buys Verve Therapeutics
Eli Lilly has confirmed plans for a $1.3 billion takeover bid for …
News
Genentech's Bittenbender named board chair at BIO
As the Biotechnology Innovation Organization (BIO) annual conference …
Oncology
IMUNON at ASCO 2025: Changing the micro-tumour environment in advanced ovarian cancer
Onsite at ASCO 2025 in Chicago, web editor Nicole Raleigh sat down …
Digital
As pharma deploys AI across the value chain, data remains a challenge
When Google shook the foundations of the biotech world with AlphaFold …
News
After rebuffing Biogen, Sage pairs off with Supernus
Sage Therapeutics has agreed to be acquired by Supernus Pharma in a …
News
J&J says two drugs are better than one in pretreated myeloma
Johnson & Johnson has new data showing that combining two of its …
R&D
When costing and compliance collide
Only a few years ago, compliance was the undisputed top priority in the pharmaceutical industry - regardless of cost.
Market Access
Sponsored
Bridging research and clinical guidelines – interactive stra...
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Biologics and Generics
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Oncology
Life Sciences Industry Report - Oncology
Developments in the oncology space in 2024 brought hope to both industry and patients.
R&D
Partner Content
16th World ADC San Diego 2025
The World’s Largest, Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference
Digital
Partner Content
Axtria Ignite 2025: Leading in an Agentic Era
Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at Forrestal in New Jersey. This